NCT04777448

Brief Summary

Balloon pulmonary angioplasty (BPA) is a new method of treatment for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) or persistent CTEPH after surgery. BPA improves or even normalises hemodynamic parameters measured during a right heart catheterization. Nevertheless, the vast majority of patients retain dyspnea and impaired exercise capacity despite considerable hemodynamic improvements. Pulmonary rehabilitation (RHB) can improve symptoms, quality of life and exercise capacity in patients with CTEPH. Unfortunately, access to RHB remains a concern in many countries. Tele-rehabilitation (tRHB) has been shown feasible and effective some cardiac or pulmonary diseases. This randomized controlled study aims at comparing the effects of tRHB with the effects of simple advices regarding exercising in CTEPH patients with normalized or near-normalized pulmonary hemodynamics after BPA treatment.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2021

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 2, 2021

Completed
28 days until next milestone

First Posted

Study publicly available on registry

March 2, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

April 1, 2021

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2023

Completed
Last Updated

March 2, 2021

Status Verified

March 1, 2021

Enrollment Period

2 years

First QC Date

February 2, 2021

Last Update Submit

March 1, 2021

Conditions

Keywords

Chronic Thromboembolic Pulmonary HypertensionTelerehabilitation

Outcome Measures

Primary Outcomes (1)

  • Difference of endurance time on cycloergometer

    Expressed in seconds and calculated as follow: endurance time after 3 months - endurance time at inclusion The two tests are performed at 80% of the maximum power reached during a maximum incremental effort test (performed before inclusion)

    At inclusion and after 3 months

Secondary Outcomes (7)

  • 6-minutes walking test (6MWT)

    At inclusion and at Month 3

  • 3-minutes chair rise test (3-CRT)

    At inclusion and at Month 3

  • SF-36

    At inclusion and at Month 3

  • Dyspnea (NYHA scale)

    At inclusion, at Month 1, Month 2 and Month 3

  • Telerehabilitation

    Through study completion, an average of 3 months

  • +2 more secondary outcomes

Study Arms (2)

Control

NO INTERVENTION

Simple physical activity advices will be given to the 27 patients of the control arm

telerehabilitation

EXPERIMENTAL

Patients in the tele rehabilitation arm will perform 24 1h-telerehabilition sessions (dance, gym, cardio training, yoga, ...)

Procedure: telerehabilitation

Interventions

24 sessions (less Thant 1h hour each) of tele rehabilitation. Patients can choose among several activities (gym, dance, cardio training, ...)

telerehabilitation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 18 years old
  • Patients who have undergone pulmonary angioplasty for CTEPH (group 4 of the international classification)
  • Patients with a mean pulmonary artery pressure \<= 30 mmHg and cardiac output \> 2.5 L/min/m2 at the last angioplasty session
  • Patients who had completed an incremental cardiopulmonary exercise test
  • Patients affiliated to the French social security system
  • Patients with signed informed consent

You may not qualify if:

  • Patients unable to complete an incremental cardiopulmonary exercise test
  • Patients unable to complete a 6-minutes walking test, 3-minutes chair raising test and a rehabilitation
  • Patient unable, for technical or any other reason, to connect via the Internet for remote monitoring and/or telerehabilitation
  • Patient for whom a refusal to participate in a rehabilitation programme is anticipated
  • Patients referred to in Articles L1121-5 to L1121-8 of the CSP (pregnant women, parturients, nursing mothers, persons deprived of their liberty by a judicial or administrative decision, persons under psychiatric care and adults subject to a legal protection measure or unable to express their consent).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Telerehabilitation

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and ServicesTelemedicineDelivery of Health CarePatient Care ManagementHealth Services Administration

Study Officials

  • Bruno Degano, MD, PhD

    CHU Grenoble Alpes

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Bruno Degano, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 2, 2021

First Posted

March 2, 2021

Study Start

April 1, 2021

Primary Completion

April 1, 2023

Study Completion

July 1, 2023

Last Updated

March 2, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share